UnitedHealth

Valuation Analysis

About the Company

UnitedHealth en bref

UnitedHealth (UNH) is currently trading at 359,29 € with a market capitalization of 326,3 Md €. The trailing P/E ratio stands at 31.25x, with a forward P/E of 18.47x. The 52-week range spans from 205,44 € to 400,23 €; the current price is 10.2% below the yearly high. Year-over-year revenue growth stands at +0.4%. The net profit margin stands at 3.14%.

💰 Dividende

UnitedHealth pays an annual dividend of 8,05 € per share, representing a yield of 2.24%. The payout ratio stands at 66.57%.

📊 Avis des analystes

26 analystes évaluent UnitedHealth (UNH) au consensus : Acheter. L'objectif de cours moyen est de 412,03 €, soit un potentiel de +14.68% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 271,37 € à 458,64 €.

UnitedHealth : la thèse d'investissement en détail

UnitedHealth (UNH) operates in the Healthcare — specifically Healthcare Plans — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Earnings growth of 61.5% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base.

Le scénario baissier

Revenue growth has slowed to just 0.4%, which is below nominal GDP — the business is no longer outgrowing the broader economy. With a net margin of just 3.14%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss.

Valorisation en contexte

The PEG ratio at 1.28 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

À surveiller

• The forward P/E of 18.47x is meaningfully below the trailing 31.25x — analysts expect earnings to step up; the next earnings release is the test.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy UnitedHealth?

Compare top-rated brokers — low fees, trusted providers, fully regulated.